维普中文期刊产品整合服务
4篇 您的检索式:作者名="Luo Quanshun"
    题名 作者 年代 出处 被引量
1用于轻金属切削的新工具涂层显示文摘新的碳基涂层已被发展用于切削轻金属 (如铝 )。这类涂层能直接用于工具上或者作为另一种硬质涂层的顶层。切削试验显示 :这类涂层对于容易粘附在工具上的材料 (如铝合金 )具有良好的切削性能 ,因为显著地减少了所谓的切屑瘤 (BUE)的出现。结果延长了工具的寿命并使工件材料在切削后表面光滑。特别是在干切削和深孔加工方面 ,涂层性能非常好。关于涂层性能的观察及原始切削结果将逐一介绍。本文也将介绍由一家主导欧洲的航空航天工业的制造商最近完成的工业领域的试验结果。切削力、切屑瘤的形成和表面粗糙度等数据将用来解释整个干切削过程。Dave Doerwald Thomas Krug Roel Tietema Wei-Ming Sim Quanshun Luo Papken Hovsepian 林松盛 代明江 2004国外金属热处理2004,25,5:7
2The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study显示文摘Objective:To assess the efficacy and safety of the novel histone deacetylase inhibitor,chidamide,in combination with cyclophosphamide,doxorubicin,vincristine,etoposide,and prednisone(Chi-CHOEP)for untreated peripheral T-cell lymphoma(PTCL).Methods:A prospective,multicenter,single arm,phase 1 b/2 study was conducted.A total of 128 patients with untreated PTCL(18–70 years of age)were enrolled between March 2016 and November 2019,and treated with up to 6 cycles with the Chi-CHOEP regimen.In the phase 1 b study,3 dose levels of chidamide were evaluated and the primary endpoint was determination of the maximumtolerated dose and recommended phase 2 dose(RP2 D).The primary endpoint of the phase 2 study was 2-year progression-free survival(PFS).Results:Fifteen patients were enrolled in the phase 1 b study and the RP2 D for chidamide was determined to be 20 mg,twice a week.A total of 113 patients were treated at the RP2 D in the phase 2 study,and the overall response rate was 60.2%,with a complete response rate of 40.7%.At a median follow-up of 36 months,the median PFS was 10.7 months,with 1-,2-,and 3-year PFS rates of 49.9%,38.0%,and 32.8%,respectively.The Chi-CHOEP regimen was well-tolerated,with grade 3/4 neutropenia occurring in approximately two-thirds of the patients.No unexpected adverse events(AEs)were reported and the observed AEs were manageable.Conclusions:This large cohort phase 1 b/2 study showed that Chi-CHOEP was well-tolerated with modest efficacy in previously untreated PTCL patients.Wei Zhang Liping Su Lihong Liu Yuhuan Gao Quanshun Wang Hang Su Yuhuan Song Huilai Zhang Jing Shen Hongmei Jing Shuye Wang Xinan Cen Hui Liu Aichun Liu Zengjun Li Jianmin Luo Jianxia He Jingwen Wang O.A.O’Connor Daobin Zhou 2021Cancer Biology & Medicine2021,18,3:4
3Effect of microstructures on the abrasive wear behaviour of spheroidal 显示文摘Luo Quanshun Xie Jingpei Song Yanpei 1995Wear1995,184,:1
4Microstructural Characteristics and Mechanical Properties of Low-Alloy, Medium-Carbon Steels After Multiple Tempering显示文摘The microstructure and mechanical properties of NiCrMoV-and NiCrSi-alloyed medium-carbon steels were investigated after multiple tempering. After austenitising, the steels were hardened by oil quenching and subsequently double or triple tempered at temperatures from 250 to 500 °C. The samples were characterised using scanning electron microscopy and X-ray diffraction, while the mechanical properties were evaluated by Vickers hardness testing, V-notched Charpy impact testing and tensile testing. The results showed that the retained austenite was stable up to 400 °C and the applied multiple tempering below this temperature did not lead to a complete decomposition of retained austenite in both steels. It was also found that the microstructure, hardness and impact toughness varied mainly as a function of tempering temperature,regardless of the number of tempering stages. Moreover, the impact toughness of NiCrMoV steel was rather similar after single/triple tempering at different temperatures, while NiCrSi steel exhibited tempered martensite embrittlement after single/double tempering at 400 °C. The observed difference was mainly attributed to the effect of precipitation behaviour due to the effect of alloying additions in the studied steels.Erfan Abbasi Quanshun Luo Dave Owens 2019Acta Metallurgica Sinica(English Letters)2019,32,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费